Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.47 |
| ▸ | BAD | Q92934 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 3/20 | 0.45 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.45 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | BRAF | P15056 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3428962 | 0.82 | MEN1 (0.50) | BCL2L1BADSHMT2ALDH1A1MEN1 | |
| SCHEMBL30505569 | 0.82 | MEN1 (0.50) | BCL2L1BADSHMT2ALDH1A1MEN1 | |
| SCHEMBL4934258 | 0.81 | SHMT2 (0.51) | EGFRSHMT2ALDH1A1MEN1LMNA | |
| SCHEMBL21625850 | 0.81 | RAPGEF4 (0.47) | EGFRRAPGEF4SHMT2ALDH1A1GRIN2D | |
| SCHEMBL19987387 | 0.81 | BCL2L1 (0.47) | BCL2L1BADEGFRALDH1A1GRIN2D | |
| SCHEMBL19993717 | 0.80 | BCL2L1 (0.46) | BCL2L1BADTSHREGFRALDH1A1 | |
| SCHEMBL12101466 | 0.79 | MEN1 (0.56) | BCL2L1BADEGFRSHMT2ALDH1A1 | |
| SCHEMBL12377131 | 0.78 | NISCH (0.51) | CYP3A4TSHRSHMT2ALDH1A1SIGMAR1 | |
| SCHEMBL4785268 | 0.78 | FADS1 (0.50) | TSHREGFRSHMT2ALDH1A1LMNA | |
| SCHEMBL19985759 | 0.76 | CCR4 (0.47) | BCL2L1BADALDH1A1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3516019-B1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2023-06-14 | — | — | EP | disclosed |
| EP-3516020-B1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2022-05-25 | — | — | EP | disclosed |
| US-10723969-B2 | Lubricant compositions stabilized by mixtures of diarylamine and hydroxydiarylamine antioxidants | LANXESS SOLUTIONS US INC. (US) | 2020-07-28 | — | — | US | disclosed |
| US-10563145-B2 | Alkylated 3-hydroxydiphenylamine antioxidants | LANXESS SOLUTIONS US INC. (US) | 2020-02-18 | — | — | US | disclosed |
| WO-2018057366-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018057364-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079987-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079987-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | GPX4, GSTO1, LPO | BCL2L1 1233/4885BAD 1771/4885CYP3A4 478/4885 |
| US-10563145-B2 | Alkylated 3-hydroxydiphenylamine antioxidants | GPX4, GSTO1, LPO | BCL2L1 1233/4885BAD 1771/4885CYP3A4 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.